CN Patent

CN101282714B — 包含前列腺素的眼用乳剂

Assigned to Sancho · Expires 2012-12-12 · 13y expired

What this patent protects

本发明涉及阳离子眼用水包油型乳剂，其包括具有被界面膜包围的油核心的胶体微粒，所述乳剂包括至少一种阳离子剂和至少一种非离子表面活性剂，所述油核心包含前列腺素，其选自下列集合：所述集合特别包括拉坦前列腺素、乌诺前列酮异丙酯、曲伏前列腺素、比马前列胺、他氟前列素、8-异前列腺素E 2 、或其混合物，用于治疗高眼压和/或青光眼。这些乳剂具有增加前列腺素的化学稳定性的性质。

USPTO Abstract

本发明涉及阳离子眼用水包油型乳剂，其包括具有被界面膜包围的油核心的胶体微粒，所述乳剂包括至少一种阳离子剂和至少一种非离子表面活性剂，所述油核心包含前列腺素，其选自下列集合：所述集合特别包括拉坦前列腺素、乌诺前列酮异丙酯、曲伏前列腺素、比马前列胺、他氟前列素、8-异前列腺素E 2 、或其混合物，用于治疗高眼压和/或青光眼。这些乳剂具有增加前列腺素的化学稳定性的性质。

Drugs covered by this patent

Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)

Patent Metadata

Patent number: CN101282714B
Jurisdiction: CN
Classification: —
Expires: 2012-12-12
Drug substance claim: No
Drug product claim: No
Assignee: Sancho
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.